Catb stock quote
The Quote Overview page gives you a snapshot view for a specific symbol. Real-time prices are provided by Cboe BZX Exchange on individual U.S. equities quote pages. During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). Volume always reflects consolidated markets. Catabasis Pharmaceuticals Inc. Stock Price (CATB) | Barron's View today's stock price, news and analysis for Catabasis Pharmaceuticals Inc. (CATB). Barron's also provides information on historical stock ratings, target prices, company earnings, market CATB Stock News - Fidelity Apr 01, 2020 · Catabasis Pharmaceuticals, Inc. (CATB), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of an aggregate of 5,290,000 shares of common stock at a public offering price of $5.00 per share, including 690,000 shares issued upon the exercise in full by the underwriter OTC Markets | CATB Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.
CATB: Catabasis Pharmaceuticals Inc - Stock Price, Quote ...
Current stock quote for Catabasis Pharmaceuticals Inc. ( CATB ) including financial statements, level 2 data, and the latest Biotechnology news, research, and Get breaking news and analysis on Catabasis Pharmaceuticals, Inc. (CATB) stock, price quote and chart, trading and investing tools. Company Name: Catabasis Pharmaceuticals, Stock Symbol: CATB, Industry: Medical - Drugs, Total Posts: 220, Last Post: 1/30/2020 CATB Detailed Quote 7 stocks under $10 to trade for big post-Brexit gains · By Roberto Pedone. Jun 26, 2016 9:31 AM EDT. We apologize for any inconvenience. Refresh or try again
CATB Stock News - Fidelity
Catabasis Pharmaceuticals Stock Forecast: up to 5.823 USD ...
30 Jan 2020 Catabasis has granted the underwriters a 30-day option to purchase up to 690,000 additional shares of common stock at the public offering price,
If You Had Bought Catabasis Pharmaceuticals (NASDAQ:CATB) Stock Three Years Ago, You'd Be Sitting On A 76% Loss, Today. Every investor on earth makes bad calls sometimes. But you have a problem if you face massive losses more than once in Catabasis Pharmaceuticals (CATB) Institutional Ownership ... Real time Catabasis Pharmaceuticals (CATB) Institutional Ownership. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. CATB Stock Quote of Catabasis Pharma
CATB - Catabasis Pharmaceuticals Inc Stock quote ...
Catabasis Pharmaceuticals (CATB) Stock Message Board ... Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics using its proprietary Safely Metabolized And Rationally Targeted, or SMART, linker technology platform.
Real-time trade and investing ideas on Catabasis Pharmaceuticals CATB from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. CATB Stock | CATABASIS PHARMACEUTICALS Stock Price Today ... CATB: Get the latest Catabasis Pharmaceuticals stock price and detailed information including CATB news, historical charts and realtime prices. CATB Catabasis Pharmaceuticals, Inc. Stock Quote Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics based on safely metabolized and rationally targeted (SMART) linker drug discovery platform in the United States.